Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 968 across all filing types
Latest filing 2024-12-30 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
关于使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is titled '现金管理进展公告' which translates to 'Cash Management Progress Announcement'. It details the company's use of idle funds for cash management, including specific financial products purchased, amounts, expected yields, and risk control measures. The document includes resolutions from board and supervisory meetings approving the cash management plan. It is an announcement about the progress and status of cash management activities rather than a full financial report or earnings release. The document length is 4185 characters, which is relatively short and consistent with an announcement rather than a comprehensive report. There is no indication of quarterly or annual financial statements, audit opinions, or detailed management discussion and analysis. Therefore, this document fits best into the category of Capital/Financing Update (CAP), as it provides updates on the company's use of funds and financial management activities.
2024-12-30 Chinese
关于回购股份实施完成暨股份变动的公告
Transaction in Own Shares Classification · 100% confidence The document is titled '关于回购股份实施完成的公告' which translates to 'Announcement on the Completion of Share Repurchase'. It details the completion of a share buyback program by the company, including specifics on the number of shares repurchased, prices, compliance with regulatory rules, and the impact on shareholding structure. The document references prior announcements about the buyback plan and adjustments to the buyback price limit. It also confirms that the buyback has been completed in accordance with the approved plan and regulatory requirements. The content is focused on the completion and results of the share repurchase, not on financial results or earnings. The document length is 3169 characters, which is relatively short and typical for an announcement rather than a full report. Therefore, this document is best classified as a 'Transaction in Own Shares' (POS) filing, which covers announcements of share repurchases or sales by the company itself.
2024-12-20 Chinese
关于回购股份比例达到1%暨回购进展的公告
Transaction in Own Shares Classification · 95% confidence The document is titled '关于回购股份的进展公告' which translates to 'Announcement on the Progress of Share Repurchase'. It details the progress of the company's share buyback program, including the number of shares repurchased, prices, total amount spent, and compliance with relevant regulations. It references previous announcements about the share repurchase plan and adjustments to the repurchase price limit. The document is an update on the ongoing share repurchase activity rather than a full financial report or initial announcement. It fits the category of a report on the company's transactions in its own shares (share repurchase). Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length is 1676 characters, which is consistent with a detailed announcement rather than a brief notice or a full report. Confidence is high due to clear content and terminology related to share repurchase progress.
2024-12-16 Chinese
关于回购股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is titled '关于回购股份的进展公告' which translates to 'Announcement on the Progress of Share Repurchase'. It details the company's share buyback plan, including the number of shares repurchased, prices, and compliance with regulatory rules. The text includes specific dates, share quantities, prices, and references to regulatory guidelines on share repurchases. The document is relatively short (1832 characters) and focuses on the progress and details of the company's share repurchase activity. This matches the definition of a 'Transaction in Own Shares' filing, which reports on the company's buyback or sale of its own shares. It is not an announcement of a report, nor a full financial report, but a progress update on share repurchase activity. Therefore, the correct classification is POS (Transaction in Own Shares).
2024-12-02 Chinese
关于公司获得医疗器械注册申请《受理通知书》的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (950 characters) about the acceptance of a medical device registration application by the National Medical Products Administration. It provides details about the product, its clinical use, and the current approval stage. There are no financial statements, no detailed financial analysis, or comprehensive report content. The document is an official announcement regarding regulatory approval status, not a financial report or management discussion. It fits best as a Regulatory Filing (RNS) because it is a regulatory announcement that does not fit into other specific categories like financial reports or management information.
2024-11-18 Chinese
关于回购股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is titled '关于回购股份的进展公告' which translates to 'Announcement on the Progress of Share Repurchase'. It details the progress of the company's share buyback program, including the number of shares repurchased, prices, and compliance with regulatory rules. It references previous announcements and regulatory guidelines but does not contain financial statements or comprehensive financial data. The document is an update on the share repurchase activity rather than a full financial report or initial announcement. Therefore, it fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back its own shares.
2024-11-04 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.